NasdaqCM - Delayed Quote USD

Anebulo Pharmaceuticals, Inc. (ANEB)

1.3900
+0.1200
+(9.45%)
At close: June 13 at 4:00:02 PM EDT
All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Cash Flow
-6,750.5740
-8,090.8490
-9,683.1330
-5,437.1740
-4,871.1890
Financing Cash Flow
14,883.3360
-62.3540
6,382.0650
0
21,831.8540
End Cash Position
13,279.9010
3,094.2000
11,247.4030
14,548.4710
19,985.6450
Interest Paid Supplemental Data
--
--
--
0
13.0530
Issuance of Capital Stock
15,000
0
6,646.7480
0
22,854.7700
Issuance of Debt
--
--
--
--
0
Repayment of Debt
--
--
--
0
-201.2860
Repurchase of Capital Stock
--
--
--
--
0
Free Cash Flow
-6,750.5740
-8,090.8490
-9,683.1330
-5,437.1740
-4,871.1890
6/30/2021 - 5/7/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ACXP Acurx Pharmaceuticals, Inc.
0.3050
-7.60%
 
ANTX AN2 Therapeutics, Inc.
1.0700
-5.31%
 
NURL.CN NeuralThera
0.0300
+20.00%
 
ELTX Elicio Therapeutics, Inc.
7.60
-5.35%
 
GDTC CytoMed Therapeutics Limited
2.0800
-2.58%
 
TSBX Turnstone Biologics Corp.
0.3345
-6.22%
 
BRNS Barinthus Biotherapeutics plc
0.9033
-3.27%
 
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1050
-2.78%
 
ADAG Adagene Inc.
1.9500
-0.51%
 
ANAB AnaptysBio, Inc.
23.32
-0.38%